Evidence map›Paper›PMID 32654691›Full record

ReviewImmunology and allergy clinics of North America2020

Chronic Lung Disease in Primary Antibody Deficiency: Diagnosis and Management.

Paul J Maglione

Open access · greenAbstract readReview
In one paragraph

Review in Immunology and allergy clinics of North America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Interstitial lung disease in infancy and early childhood: a clinicopathological primer.European respiratory review : an official journal of the European Respiratory Society · 2022
    Review
  5. Article
  6. Review
  7. Article
  8. Clinical disparity of primary antibody deficiency patients at a safety net hospital.The journal of allergy and clinical immunology. In practice · 2021
    Article
  9. State-of-the-art diagnostic evaluation of common variable immunodeficiency.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2021
    Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Paul J MaglionePulmonary Center, Boston University School of Medicine, 72 East Concord Street, R304, Boston, MA 02118, USA. Electronic address: pmaglion@bu.edu.
Boston University · US

Funding

Role of B cell activating factor in non-infectious complications of common variable immunodeficiencyK23AI137183 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MAGLIONE, PAUL JOSEPH · 2018 to 2022
$945k
Mechanisms of immune dysregulation due to NFKB1 mutation in common variable immunodeficiencyR21AI151486 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MAGLIONE, PAUL JOSEPH · 2020 to 2021
$454k
NIAID NIH HHS K23 AI137183NIAID NIH HHS R21 AI151486
6 · The paper itself

Abstract

Chronic lung disease is a complication of primary antibody deficiency (PAD) associated with significant morbidity and mortality. Manifestations of lung disease in PAD are numerous. Thoughtful application of diagnostic approaches is imperative to accurately identify the form of disease. Much of the treatment used is adapted from immunocompetent populations. Recent genomic and translational medicine advances have led to specific treatments. As chronic lung disease has continued to affect patients with PAD, we hope that continued advancements in our understanding of pulmonary pathology will ultimately lead to effective methods that alleviate impact on quality of life and survival.

Indexed as

BiomarkersChronic DiseaseDiagnosis, DifferentialDiagnostic ImagingDisease ManagementDisease SusceptibilityFluorescent Antibody TechniqueHumansImmunohistochemistryLung DiseasesPrimary Immunodeficiency DiseasesSymptom AssessmentBiomarkersAsthmaBronchiectasisCommon variable immunodeficiencyGLILDInterstitial lung diseaseLung diseasePrimary antibody deficiency

Identifiers

PMID32654691
PMCPMC7366316
OpenAlexW3035666729

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.